首頁 > 市場調查報告書 > 製藥

藥物開發人工智能人工智能藥物研發

市場調查報告書

商品編碼

2148322

人工智慧藥物發現市場：按產品/服務、技術、藥物發現流程、藥物類型、應用、最終用戶和地區分類

AI in Drug Discovery Market, By Offering, By Technology, By Drug Discovery Process, By Drug Type, By Application, By End User, By Geography

出版日期: 2026年09月23日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人工智慧藥物發現市場規模將達到32.4億美元，到2033年將達到155.362億美元。預計從2026年到2033年，該市場將以25.1%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	32.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	25.10%	2033年市場規模預測：	155.362億美元

人工智慧（AI）正在革新藥物研發領域的發現過程，加速新型治療化合物的識別、開發和最佳化。研究人員正利用機器學習、深度學習、自然語言處理和生成式人工智慧技術，改進複雜生物數據的分析，預測分子間相互作用，識別藥物靶點，並增強虛擬篩檢和先導化合物最佳化。

人工智慧利用基因組、蛋白質、生物標記和臨床數據產生多維度洞察，有望提高藥物發現的效率和準確性。製藥公司、生物技術公司和研究機構擴大採用人工智慧驅動的平台，這正在推動更高效的藥物發現工作流程的建立，並促進全球人工智慧驅動藥物發現市場的擴張。

市場動態

全球人工智慧藥物發現市場的發展動力源於傳統藥物發現成本和複雜性的不斷攀升、製藥業研發投入的持續成長以及基因組學、蛋白質組學和化學數據量的激增。人工智慧正在加速標靶識別、虛擬篩檢、先導化合物最佳化和藥物性質預測等流程。此外，科技公司與製藥公司之間日益深入的合作也推動了人工智慧在整個藥物發現過程中的應用。

然而，市場面臨許多限制因素，包括標準化問題、資料隱私和智慧財產權擔憂、監管不確定性以及人工智慧和生命科學領域雙料人才短缺。儘管如此，生成式人工智慧在從頭分子設計、罕見疾病人工智慧療法開發以及人工智慧在亞太和拉丁美洲等新興市場的應用推廣方面仍蘊藏著巨大的機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球人工智慧藥物發現市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球人工智慧藥物發現市場報告》的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以利用各種策略矩陣來分析人工智慧在藥物發現領域的全球市場，從而簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Schrodinger, Inc.
Insilico Medicine
Recursion Pharmaceuticals, Inc.
Isomorphic Labs Limited
XtalPi Inc.
insitro, Inc.
BenevolentAI
Generate Biomedicines, Inc.
Owkin, Inc.
Atomwise, Inc.

第12章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10138

AI in Drug Discovery Market is estimated to be valued at USD 3,240.0 Mn in 2026 and is expected to reach USD 15,536.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 25.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,240.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	25.10%	2033 Value Projection:	USD 15,536.2 Mn

Artificial intelligence (AI) is revolutionizing drug discovery in pharmaceutical research by accelerating the identification, development and optimization of novel therapeutic compounds. Researchers are using machine learning, deep learning, natural language processing, and generative AI techniques to analyze complex biological data, predict molecular interactions, identify drug targets, and improve virtual screening and lead optimization.

AI leverages genomic, protein, biomarker and clinical data to generate multidimensional insights that may improve the efficiency and accuracy of drug discovery. The increasing adoption of AI-driven platforms by pharmaceutical companies, biotech firms and research institutes is leading to the creation of more efficient discovery workflows and fueling the expansion of the Global AI in Drug Discovery Market.

Market Dynamics

The global AI in drug discovery market is driven by the escalating cost and complexity of traditional drug discovery, increasing pharmaceutical R&D expenditure, and the mounting volume of genomic, proteomic, and chemical data. AI is accelerating processes such as target identification, virtual screening, lead optimization, and drug property prediction. Furthermore, the increasing collaborations between technology and pharmaceutical companies are fueling the adoption of AI across the drug discovery process.

However, a number of constraints are present in the market, such as standardization issues, data privacy and intellectual property concerns, regulatory uncertainty, and a shortage of professionals with combined AI and life sciences expertise. Nevertheless, significant opportunities exist in generative AI for de novo molecule design, AI-enabled development of therapies for rare diseases, and growing adoption in emerging markets such as Asia-Pacific and Latin America.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global AI in drug discovery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Schrodinger, Inc., Insilico Medicine, Recursion Pharmaceuticals, Inc., Isomorphic Labs Limited, XtalPi Inc., insitro, Inc., BenevolentAI, Generate Biomedicines, Inc., Owkin, Inc., and Atomwise, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global AI in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in drug discovery market

Market Segmentation

Offering Insights (Revenue, USD Mn, 2021 - 2033)
- Software
- Services
Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Machine Learning
- Deep Learning
- Generative AI
- Natural Language Processing
- Others
Drug Discovery Process Insights (Revenue, USD Mn, 2021 - 2033)
- Target Identification and Validation
- Hit Identification and Screening
- Lead Identification and Optimization
- Preclinical Development
Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small-Molecule Drugs
- Large-Molecule Drugs
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Drug Repurposing
- De Novo Drug Design
- Virtual Screening
- Biomarker Discovery
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Schrodinger, Inc.
- Insilico Medicine
- Recursion Pharmaceuticals, Inc.
- Isomorphic Labs Limited
- XtalPi Inc.
- insitro, Inc.
- BenevolentAI
- Generate Biomedicines, Inc.
- Owkin, Inc.
- Atomwise, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global AI in Drug Discovery Market, By Offering
- Global AI in Drug Discovery Market, By Technology
- Global AI in Drug Discovery Market, By Drug Discovery Process
- Global AI in Drug Discovery Market, By Drug Type
- Global AI in Drug Discovery Market, By Application
- Global AI in Drug Discovery Market, By End User
- Global AI in Drug Discovery Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Offering Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global AI in Drug Discovery Market, By Offering, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global AI in Drug Discovery Market, By Technology, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Machine Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Deep Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Generative AI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Natural Language Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global AI in Drug Discovery Market, By Drug Discovery Process, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Target Identification and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Hit Identification and Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lead Identification and Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Preclinical Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global AI in Drug Discovery Market, By Drug Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Small-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Large-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global AI in Drug Discovery Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Drug Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
De Novo Drug Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Virtual Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Biomarker Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global AI in Drug Discovery Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global AI in Drug Discovery Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Schrodinger, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Insilico Medicine
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Recursion Pharmaceuticals, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Isomorphic Labs Limited
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
XtalPi Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
insitro, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
BenevolentAI
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Generate Biomedicines, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Owkin, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
Atomwise, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies